Darifenacin blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. It is a medication used to treat urinary incontinence.. Reference standards of Darifenacin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Darifenacin
Catalogue No.:PA 31 25000
CAS :
Molecular Formula : C28H30N2O2
Molecular Weight : 426.55
rac Darifenacin-d4
Catalogue No.:PA STI 024370
Molecular Formula : C28H26D4N2O2
Molecular Weight : 430.57
(R)-Darifenacin-d4 Hydrobromide
Catalogue No.:PA STI 024380
Molecular Formula : C28H27D4BrN2O2
Molecular Weight : 511.49
Darifenacin-d4 Hydrobromide
Catalogue No.:PA STI 024381
(R)-Darifenacin-d4
Catalogue No.:PA STI 024390
5-(2-Hydroxyethyl)-2,3-dihydrobenzofuran-d4
Catalogue No.:PA STI 050150
Molecular Formula : C10H8D4O2
Molecular Weight : 168.23
Darifenacin Hydrobromide (1164200)
Catalogue No.:PA USP1164200
Molecular Formula : NA
Molecular Weight : NA
Darifenacin Peak ID Mixture (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darife (1164222)
Catalogue No.:PA USP1164222
α,α-Diphenyl-3-pyrrolidineacetamide
Catalogue No.:PA 31 0251000
Molecular Formula : C18H20N2O
Molecular Weight : 280.37
Darifenacin(acetic Acid) Des-(5-Ethyl-2,3-dihydrobenzofuran)
Catalogue No.:PA 31 0251001
Molecular Formula : C18H19NO2
Molecular Weight : 281.36
2,3-Dihydrobenzofuran-5-acetic Acid
Catalogue No.:PA 31 0251002
Molecular Formula : C10H10O3
Molecular Weight : 178.19
Darifenacin chiral peak identification mixture
Catalogue No.:PA 31 0251003
Molecular Formula : C28H31BrN2O2
Molecular Weight : 507.47
Darifenacin Hydrobromide, Dealkyl darifenacin, Ketodarifenacin and 7-Bromo darifenacin
Catalogue No.:PA 31 0251004
2,3-Dihydro-5-benzofuranethanol
Catalogue No.:PA 31 0251005
Molecular Formula : C10H12O2
Molecular Weight : 164.2
(S)-N-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
Catalogue No.:PA 31 0251006
Molecular Formula : C38H40N2O3
Molecular Weight : 572.75
Tert-butyl 3-(cyanodiphenylmethyl)pyrrolidine-1-carboxylate
Catalogue No.:PA 31 0251007
Molecular Formula : C23H26N2O2
Molecular Weight : 362.47
Darifenacin 4-Hydroxy Impurity
Catalogue No.:PA 31 0251008
2-(1-(4-Hydroxy-3-(2-hydroxyethyl)phenethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
Catalogue No.:PA 31 0251009
Molecular Formula : C28H32N2O3
Molecular Weight : 444.58
(S)-1-Tosylpyrrolidin-3-ol
Catalogue No.:PA 31 0251010
Molecular Formula : C11H15NO3S
Molecular Weight : 241.31
(S)-3-Benzhydryl-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine
Catalogue No.:PA 31 0251011
Molecular Formula : C27H29NO
Molecular Weight : 383.54
(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile oxalate
Catalogue No.:PA 31 0251012
Molecular Formula : C20H20N2O4
Molecular Weight : 352.39
2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
Catalogue No.:PA 31 0251013
Molecular Weight : 426.56
(S)-2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl-1,1,2,2-d4)pyrrolidin-3-yl)-2,2-diphenylacetamide
Catalogue No.:PA 31 0251014
Molecular Weight : 430.58
3-(2-Amino-2-oxo-1,1-diphenylethyl)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine 1-oxide
Catalogue No.:PA 31 0251015
Molecular Formula : C28H30N2O3
Molecular Weight : 442.56
(S)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetamide
Catalogue No.:PA 31 0251016
(S)-N,N-bis(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-2,2-diphenyl-2-(pyrrolidin-3-yl)acetamide
Catalogue No.:PA 31 0251017
(S)-1-Nitrosopyrrolidin-3-ol
Catalogue No.:PA 31 0251018
Molecular Formula : C4H8N2O2
Molecular Weight : 116.12
Darifenacin Cyano Pyrrolidine Nitroso Impurity
Catalogue No.:PA 31 0251019
Molecular Formula : C18H17N3O
Molecular Weight : 291.35
Darifenacin Amide Nitroso Impurity
Catalogue No.:PA 31 0251020
Molecular Formula : C18H19N3O2
Molecular Weight : 309.37
N-(2-Aminophenyl)-N-methyl nitrous amide
Catalogue No.:PA 31 0251021
Molecular Formula : C7H9N3O
Molecular Weight : 151.17
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
